Výsledky vyhledávání - "Bradley S Miller"

Akademický článek

Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis

Autor: Kevin C J Yuen, Gudmundur Johannsson, Ken K Y Ho, Bradley S Miller, Ignacio Bergada, Alan D Rogol

Publikováno v: Endocrine Connections, Vol 12, Iss 7, Pp 1-19 (2023)

Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficie ncies. Although diminished height velocity and short stature are useful and important clin ical marker

Externí odkaz: https://doaj.org/article/d648e617175949ae9a9510acf8088a7a

Zobrazit plný text záznamu

Akademický článek

Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female

Autor: Danielle R Bullock, Bradley S Miller, H Brent Clark, Patricia M Hobday

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2018)

IgG4-related hypophysitis is an important diagnostic consideration in patients with a pituitary mass or pituitary dysfunction and can initially present with headaches, visual field deficits and/or endocrine dysfunction. Isolated IgG4-related pituitar

Externí odkaz: https://doaj.org/article/e90cdde8a4044b109c2e3814600296b4

Zobrazit plný text záznamu

Growth Hormone Deficiency in Childhood Intracranial Germ Cell Tumor Survivors

Autor: Diana W. Lone, Karim T. Sadak, Bradley S. Miller, Jeannette M. Sample, Aubrey K. Hubbard, Caryn Wolter, Michelle Roesler, Michelle Nuno, Jenny N. Poynter

Publikováno v: J Endocrinol Metab

BACKGROUND AND AIMS: Intracranial germ cell tumor (iGCT) survivors have multiple risk factors for growth hormone (GH) deficiency, a commonly reported late effect in childhood cancer survivors. The objective of this study is to examine the prevalence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f829b55c2ff2afe8e866414102c83c1
https://pubmed.ncbi.nlm.nih.gov/36249955

Zobrazit plný text záznamu

Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients

Autor: Bradley S Miller, Kevin CJ Yuen

Publikováno v: Drug Design, Development and Therapy. 16:2055-2066

Lonapegsomatropin, a long-acting GH therapy (LAGH), was approved by the United States Food and Drug Administration in August 2021 for the treatment of pediatric growth hormone deficiency (GHD). Lonapegsomatropin is a prodrug consisting of unmodified

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c5e87f62b9f9539b4bbc9e967ee6fc
https://doi.org/10.2147/dddt.s336285

Zobrazit plný text záznamu

Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency

Autor: Jane Loftus, Bradley S. Miller, Craig S. Parzynski, Jose Alvir, Yong Chen, Priti Jhingran, Anu Gupta, Mitch DeKoven, Victoria Divino, Jenny Tse, Jing He, Michael Wajnrajch

Publikováno v: Endocrine Practice. 28:565-571

Recombinant human growth hormone (somatropin) is recommended for children with growth hormone deficiency (GHD) to normalize adult height. Prior research has indicated an association between adherence to somatropin and height velocity. Further researc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d50dbaea5e8f6516a1153191967f9d
https://doi.org/10.1016/j.eprac.2022.02.013

Zobrazit plný text záznamu

Approach to the Patient- Case Studies in Pediatric Growth Hormone Deficiency and Their Management

Autor: Rohan K Henry, Bradley S Miller

Publikováno v: The Journal of Clinical Endocrinology & Metabolism.

Context Pathologies attributed to perturbations of the growth hormone/insulin like growth factor-I (GH/IGF-I) axis are among the most common referrals received by pediatric endocrinologists. Aim In this article, distinctive cased-based presentations

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df5787925d1db096bfffad35e3587d25
https://doi.org/10.1210/clinem/dgad305

Zobrazit plný text záznamu

Diagnosis and testing for growth hormone deficiency (GHD) across the ages: a global view of the accuracy, caveats and cut-offs for diagnosis

Autor: Kevin C J Yuen, Gudmundur Johannsson, Ken K Y Ho, Bradley S. Miller, Ignacio Bergada, Alan D Rogol

Publikováno v: Endocrine Connections.

Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75d70bea335fcab7f421f3404590ef8c
https://doi.org/10.1530/ec-22-0504

Zobrazit plný text záznamu

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program

Autor: Philippe Backeljauw, Joanne C Blair, Jean-Marc Ferran, Nicky Kelepouris, Bradley S Miller, Alberto Pietropoli, Michel Polak, Lars Sävendahl, Franciska Verlinde, Tilman R Rohrer

Publikováno v: The Journal of Clinical Endocrinology & Metabolism.

Context Despite having normal growth hormone (GH) secretion, individuals with Turner syndrome (TS) have short stature. Treatment with recombinant human GH is recommended for TS girls with short stature. Objective This work aimed to evaluate the effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cdc6a6af84f5bac8b13eb4d1c8b5c6ee
https://doi.org/10.1210/clinem/dgad159

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání